Study of L-NDDP (Aroplatin) in Patients With Advanced Solid Malignancies or B-Cell Lymphoma
Condition(s):Malignancies; B-Cell LymphomaLast Updated:October 27, 2008Completed
Hide Studies Not Open or Pending
Condition(s):Malignancies; B-Cell LymphomaLast Updated:October 27, 2008Completed
Condition(s):Advanced Solid Tumors With Alterations of FGFR1, 2 and or 3; Squamous Lung Cancer With FGFR1 Amplification; Bladder Cancer With FGFR3 Mutation or Fusion; Advanced Solid Tumors With FGFR1 Amplication; Advanced Solid Tumors With FGFR2 Amplication; Advanced Solid Tumors With FGFR3 MutationLast Updated:October 4, 2019Completed
Condition(s):Advanced Solid MalignanciesLast Updated:December 2, 2009Unknown status
Condition(s):Advanced Solid TumorLast Updated:December 3, 2021Terminated
Condition(s):Solid Tumor; NeoplasmsLast Updated:April 24, 2023Completed
Condition(s):Solid TumorLast Updated:March 6, 2024Active, not recruiting
Condition(s):Solid Tumor, AdultLast Updated:February 13, 2020Unknown status
Condition(s):Solid Tumors; Lung CancerLast Updated:March 19, 2018Completed
Condition(s):Cancer, MetastaticLast Updated:June 18, 2015Terminated
Condition(s):Solid Tumor; LymphomaLast Updated:February 20, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.